Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

PRICED: Bausch + Lomb E675m 5.5NC1 sr sec FRN E+387.5p at 99.50

HYC US Market: Deal Flow - GeneralHYC European Market: Deal Flow - General

Bausch + Lomb Netherlands BV (Dutch Co-Issuer) and Bausch + Lomb Inc (US Co-Issuer) (BLCO, BLCOCN) EUR675m (up from EUR600m) 144A sr sec FRN due 01/15/31 (5.5y). NC1 (06/30/26) (MWC B+50bp), then at 100. Equity claw: 1y 40% at 103.875. B1/B/BB (stable/developing/Rating Watch Evolving). Via JPM (B&D)/Barc/Citi/GS/HSBC/WFS jt books, DB, DNB, RBC, TSI as co-managers. No reg rights. List ISE. NY law. CoC at 101. Pays Jan 15, Apr 15, July 15, Oct 15, starting 01/15/26. Settles 06/26. Reg S ISIN: XS3102032201; 144A ISIN: XS3102032110. IPT: E+425-450bp at 99.00 OID. Price talk 3mE+425bp area (+/- 12.5bp) at 99.50. EUR75m upsize and US$125m upsize to repay EUR160m revolver draw in full. Revised price talk: E+400bp area (+/- 12.5bp), 0% floor at 99.50 OID.

Priced: 3mE+387.5bp, 0% floor at 99.50. 

Did investor call at 4pm UKT 06/11. Books close at 12pm UKT 06/18. UOP: along with $2.325bn (up from $2.2bn) term loan B via JPM (lender call 1:30pm 06/12, commitments due 12pm (from 5pm) 06/17) (originally with a $160m draw on its new $800m (up from $500m) revolver), to repay its existing $160m revolver draw, refinance in full its $2.431bn term loan B due May 2027, and $398m term loan A due May 2027, GCP. Biz: producer and marketer of eye care and sight products. HQ: Vaughan, ON.

Netroadshow direct link: https://www.netroadshow.com/nrs/home/#!/?show=14f09406. Entry code: BLCO2025

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.